Myoblast transplantation for cardiac repair: a clinical perspective (Q35637507)

9 August 2017

1 reference

title

Myoblast transplantation for cardiac repair: a clinical perspective (English)

1 reference

9 August 2017

0 references

Husnain Kh Haider

1

1 reference

9 August 2017

Alvin C K Tan

2

1 reference

9 August 2017

Salim Aziz

3

1 reference

9 August 2017

Juan C Chachques

4

1 reference

9 August 2017

Eugene K W Sim

5

1 reference

9 August 2017

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

9

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

14-23

1 reference

Cardiac cell transplantation: closer to bedside.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Effectiveness of the clinical pathway in the management of congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Beta-blocker therapy and severe heart failure: myth or reality?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

[Surgical therapy of end-stage heart failure]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Surgical treatment for chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

From dynamic to cellular cardiomyoplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Therapeutic cardiac angiogenesis and myogenesis: the promises and challenges on a new frontier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Cellular cardiomyoplasty: a new hope in heart failure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Control of cardiac muscle cell division

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Myocyte growth and cardiac repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Evidence that human cardiac myocytes divide after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Myocyte death, growth, and regeneration in cardiac hypertrophy and failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Myocyte transplantation for myocardial repair: a few good cells can mend a broken heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Stem cells in cardiovascular disease: from cell biology to clinical therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Myocyte and myogenic stem cell transplantation in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Autologous cell transplantation for the treatment of damaged myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Muscle cell grafting for the treatment and prevention of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Cell transplantation to improve ventricular function in the failing heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Therapeutic angiogenesis induced by local autologous bone marrow cell implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Incorporation and integration of implanted myogenic and stem cells into native myocardial fibers: anatomic basis for functional improvements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Angiogenesis by means of endothelial cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

The use of ex vivo gene transfer based on muscle-derived stem cells for cardiovascular medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Cell transplantation as future therapy for cardiovascular disease?: A workshop of the National Heart, Lung, and Blood Institute

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

28. Embryonic and adult stem cell therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Autologous cardiomyocyte transplantation in an ovine myocardial infarction model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Smooth muscle cells transplantation is better than heart cells transplantation for improvement of heart function in dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Cardiomyocyte transplantation improves heart function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Transplantation of neonatal cardiomyocytes after permanent coronary artery occlusion increases regional blood flow of infarcted myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Physiological Coupling of Donor and Host Cardiomyocytes After Cellular Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Cellular therapy reverses myocardial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Myoblast transplantation for heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Autologous bone-marrow stem-cell transplantation for myocardial regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Clinical cellular cardiomyoplasty: technical considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Treatment of heart failure with autologous skeletal myoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Cellular and molecular reactions in mouse muscles after myoblast implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Dynamics of the early immune cellular reactions after myogenic cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

A role for natural killer cells in the rapid death of cultured donor myoblasts after transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Exposure to tissue culture conditions can adversely affect myoblast behavior in vivo in whole muscle grafts: implications for myoblast transfer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Myoblast transplantation: feasibility, safety and efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Endoventricular porcine autologous myoblast transplantation can be successfully achieved with minor mechanical cell damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Endoventricular transplantation of allogenic skeletal myoblasts in a porcine model of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

Incomplete retention after direct myocardial injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.009

10.1016/J.YMTHE.2003.10.009

7 January 2021

Identifiers

DOI

1 reference

9 August 2017

1 reference